glp -1 agonist GLP-1 receptor agonists show promise in treating substance use disorders Impact of GLP- 1 Receptor
Description
People are losing 15, 20 percent of their body weight
Obesity and Type 2 diabetes represent global health challenges, and there is an unmet need for long-lasting and effective pharmacotherapies
GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing
Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk
2023 2 Minute Medicine, Inc
